Ascentage Pharma Group International (AAPG) Other Non-Current Assets (2023 - 2025)

Ascentage Pharma Group International (AAPG) has reported Other Non-Current Assets for 3 consecutive years, with $4.3 million the latest figure, recorded in Q4 2025.

• Quarterly Other Non-Current Assets fell 47.53% year-over-year to $4.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.3 million (down 47.53% YoY) and the FY2025 annual result came in at $99000.0, up 141.46% from the prior year.
• Other Non-Current Assets fell to $4.3 million in Q4 2025 per AAPG's latest filing, from $13.8 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for AAPG reached as high as $13.8 million in Q2 2025 and fell as low as $22916.4 in Q4 2023.
• A 3-year average of $6.6 million and a median of $6.3 million in 2024 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2024 — Other Non-Current Assets jumped 35926.18% — and 2025, when it sank 47.53%.
• Year by year, Other Non-Current Assets stood at $22916.4 in 2023, then soared by 35926.18% to $8.3 million in 2024, then plunged by 47.53% to $4.3 million in 2025.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $4.3 million, $13.8 million, and $8.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.